Scout | PAR-24-222: NINDS SBIR Phase IIB Bridge Awards for Preclinical Neurology Products (R44, no clinical trials)

This opportunity is no longer accepting applications.

grant PAR-24-222

NINDS SBIR Phase IIB Bridge Awards for Preclinical Neurology Products (R44, no clinical trials)

Summary

NINDS offers SBIR Phase IIB renewal awards to extend prior Phase II projects for preclinical product development or complex research tools in neurology; clinical trials are not allowed. Applicants must build on prior NIH SBIR/STTR work and secure substantial third-party investment (often matching NINDS funds, with reduced requirements for small markets) to advance toward regulatory approval an…

Purpose

NINDS is committed to advancing treatments, tools, and diagnostics that benefit people burdened by neurological diseases through the NINDS Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. The SBIR/STTR Programs are structured in thr…

Funding Source

Agency: National Institutes of Health

Sub-agency: National Institute of Neurological Disorders and Stroke

Phase: Phase II

Awards & funding

Award Ceiling: $2M

Eligibility

Joint ventures in which each entity meets SBIR/STTR SBC eligibility; joint venture must have less than 50% participation by foreign business entities

U.S. Small Business Concerns majority-owned by multiple venture capital operating companies, hedge funds, or private equity firms (eligible for SBIR only; not eligible for STTR)

Key eligibility requirements and restrictions

Only United States Small Business Concerns (SBCs) may apply. The applicant must: (1) be organized for profit with a place of business in the U.S., operating primarily in the U.S. or making a significant contribution to the U.S. economy; …

Dates

Opportunity Released: June 21, 2024

Open for Submission: June 21, 2024

Submission Deadline: April 5, 2027

Application Window Closes: April 5, 2027

Supporting links

National Institutes of Health

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers